The summary of the research - clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG Immunotherapy is given below.
<h3>What is the summary of the above research?</h3>
Urinary bladder carcinoma in situ (CIS) is a flat, high-grade, and aggressive form of urothelial cancer with a high likelihood of development to muscle-invasive illness and metastatic dissemination.
The study's goal was to compare the clinical histories and survival rates of primary, secondary, and concurrent CIS of the bladder.
Learn more about Immunotherapy at brainly.com/question/14493516
#SPJ1
<span>The statement that "A centralized structure does not provide information from local stores that would be useful in changing its technology quickly is an example that illustrates the effect of structure on strategy" is true.
</span><span> Changes in the external environment are the reason why changes in the technology and emergence of dynamic technological advancements should be done.</span>
Answer:
Giving that: The following is a sequence of undo-log records written by 2 transactions T and U:
< START T >;
< T,A,10 >;
< START U >;
< U, B, 20 >;
< T, C, 30 >;
< U, D, 40 >;
< Commit U >;
< T, E, 50 >;
< Commit T >;
1. < START U >
Recovery action in this case will be undo(-1) and undo(0). All restored to its original Value
log records < T, A, 10 >, < T, abort >; as written out
2. < T, E, 50 >
Recovery action in this case will be undo(8) and redo(0). A and C is restored to its original value, B and D are set to 20 and 40
log records <T, C, 30 >, < T, A, 10 >, < T, abort > are written out
3. < Commit T >
Recovery action in this case will be redo(7) and redo(4). A and C are set to 10 and 30, B and D are set to 20 and 40
Answer:
0 1 2 However many you like
✓ I think its 2x they will start to define the program
Application I think because software used to create a program is called application software I'm not entirely sure about that though
